Gill Measure to Expand Access to Alzheimer’s Treatment Signed by Governor

CHICAGO – A measure led by state Rep. Mary Gill, D-Chicago, to further require health insurance providers to cover medication that slows the progression of Alzheimer’s Disease and other related dementias was signed into law by Gov. J.B. Pritzker Monday.

“Today we took a strong step forward to make Illinois a national leader when it comes to Alzheimer’s treatment and helping people access the healthcare they deserve,” Gill said. “When it comes to slowing Alzheimer’s and other dementias, every moment counts. We can’t waste time on insurance gimmicks like step therapy to save a few bucks, which is why I’m thankful for the strong advocacy and bipartisan support this legislation received.”

Gill worked with the Alzheimer’s Association and state Sen. Laura Murphy to pass Senate Bill 126, which requires health insurance providers to cover medication that slows the progression of Alzheimer’s Disease and other related dementias. Such coverage includes all medically necessary diagnostic testing and medication approved by the U.S. Food and Drug Administration. Insurance providers would be prohibited from utilizing “step therapy,” a strategy that involves using different, less costly treatments requiring patients to “fail first” before receiving what was prescribed.

The measure’s requirements would apply to private health insurance plans regulated by the state, self- insuring counties, self-insuring municipalities, self-insuring school districts, Health Maintenance Organizations (HMOs) and Limited Health Service Organizations. HMOs under contract with the Department of Healthcare and Family Services are exempt.

For more information, please contact RepMaryGill@gmail.com.